Post-IPO Equity - Kythera Biopharmaceuticals
Investment Firm
Overview
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
Announced Date
Oct 07, 2013
Closed on Date
Oct 15, 2013
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Kythera Biopharmaceuticals raised $134000000 on 2013-10-07 in Post-IPO Equity
Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 19, 2011 |  Series D - Kythera Biopharmaceuticals | 8 | - | 37.4M |
| Sep 16, 2005 | Seed Round - Kythera Biopharmaceuticals | 1 | - | 1.0M |
| Jul 24, 2006 | Series B - Kythera Biopharmaceuticals | 6 | - | 30.0M |
| May 19, 2008 | Series C - Kythera Biopharmaceuticals | 8 | - | 30.0M |